Sarah Hamidi, MD, FRCPC is a board-certified endocrinologist with specialized training in oncologic endocrinology, completed through a two-year fellowship at The University of Texas MD Anderson Cancer Center. She currently serves as an Assistant Professor (Term Tenure Track) in the Department of Endocrine Neoplasia and Hormonal Disorders at MD Anderson. Dr. Hamidi’s clinical and research efforts focus on advanced thyroid cancers, with a particular emphasis on anaplastic thyroid cancer. She is actively involved in clinical trials and translational research aimed at improving outcomes in this rare and highly aggressive malignancy.